Analysts Still Hopeful on China Drugmakers After 2018 Rout

Bookmark
(Bloomberg) -- Analysts’ price targets on Chinese health-care stocks are looking optimistic after a sell-off in the sector accelerated toward the end of last year.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.